LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics Synthekine specializes in engineered cytokine therapeutics targeting cancer and autoimmune diseases, with promising preclinical results that suggest strong potential for novel treatment options among healthcare providers seeking cutting-edge immunotherapies.

Strategic Collaborations The company's partnership with Sanofi for developing IL-10 receptor agonists indicates an openness to joint ventures and licensing deals, creating opportunities for pharmaceutical companies to co-develop or commercialize innovative immune-modulatory therapies.

Recent Product Launches Synthekine's recent clinical presentations, including the PD-L1 Negative therapy, highlight ongoing advancement in personalized oncology treatments, offering potential sales channels in clinical trial supplies and early-access programs for innovative cancer therapies.

Funding and Growth With substantial funding of 190 million dollars and revenue between 25 and 50 million dollars, Synthekine is well-positioned for expansion and new product development, presenting opportunities for strategic investment, partnership, or supply chain engagement.

Market Focus Areas The company’s focus on immuno-oncology, autoimmune disorders, and inflammatory diseases aligns well with current market trends, indicating potential demand from biopharma companies, research institutions, and healthcare providers seeking next-generation immune therapies.

Synthekine Tech Stack

Synthekine uses 8 technology products and services including jsDelivr, RSS, Chart.js, and more. Explore Synthekine's tech stack below.

  • jsDelivr
    Content Delivery Network
  • RSS
    Content Management System
  • Chart.js
    Javascript Graphics
  • Underscore.js
    Javascript Libraries
  • All in One SEO
    Search Engines
  • Cloudflare Bot Management
    Security
  • GoDaddy
    Web Hosting
  • Gravity Forms
    Web Platform Extensions

Media & News

Synthekine's Email Address Formats

Synthekine uses at least 1 format(s):
Synthekine Email FormatsExamplePercentage
FLast@synthekine.comJDoe@synthekine.com
50%
FLast@synthekine.comJDoe@synthekine.com
50%

Frequently Asked Questions

Where is Synthekine's headquarters located?

Minus sign iconPlus sign iconSynthekine's main headquarters is located at 1505 Obrien Drive Suite a Menlo Park, California 94025 United States. The company has employees across 1 continents, including North America.

What is Synthekine's official website and social media links?

Minus sign iconPlus sign iconSynthekine's official website is synthekine.com and has social profiles on LinkedInCrunchbase.

What is Synthekine's SIC code NAICS code?

Minus sign iconPlus sign iconSynthekine's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Synthekine have currently?

Minus sign iconPlus sign iconAs of March 2026, Synthekine has approximately 69 employees across 1 continents, including North America. Key team members include Head Of It: A. B.Vice President, Translational & Bioanalytical Sciences: A. M.Sr. Director, Program Management: H. Z.. Explore Synthekine's employee directory with LeadIQ.

What industry does Synthekine belong to?

Minus sign iconPlus sign iconSynthekine operates in the Biotechnology Research industry.

What technology does Synthekine use?

Minus sign iconPlus sign iconSynthekine's tech stack includes jsDelivrRSSChart.jsUnderscore.jsAll in One SEOCloudflare Bot ManagementGoDaddyGravity Forms.

What is Synthekine's email format?

Minus sign iconPlus sign iconSynthekine's email format typically follows the pattern of FLast@synthekine.com. Find more Synthekine email formats with LeadIQ.

How much funding has Synthekine raised to date?

Minus sign iconPlus sign icon As of March 2026, Synthekine has raised $190M in funding. The last funding round occurred on Jun 10, 2021 for $108M.

When was Synthekine founded?

Minus sign iconPlus sign iconSynthekine was founded in 2018.

Synthekine

Biotechnology ResearchCalifornia, United States51-200 Employees

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious. Its lead programs have shown promising efficacy and tolerability in preclinical studies, and it is developing additional cytokine partial agonists that selectively modulate key pathways of the immune system.

Section iconCompany Overview

Headquarters
1505 Obrien Drive Suite a Menlo Park, California 94025 United States
Website
synthekine.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $190M

    Synthekine has raised a total of $190M of funding over 2 rounds. Their latest funding round was raised on Jun 10, 2021 in the amount of $108Mas a Series B.

  • $25M$50M

    Synthekine's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $190M

    Synthekine has raised a total of $190M of funding over 2 rounds. Their latest funding round was raised on Jun 10, 2021 in the amount of $108Mas a Series B.

  • $25M$50M

    Synthekine's revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    A. B.
    Head Of It
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Vice President, Translational & Bioanalytical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. Z.
    Sr. Director, Program Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. R.
    Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. J.
    Associate Director
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. O.
    Director Of Quality And Compliance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. P. A.
    Director Of Cell Therapy
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G.
    Global Regulatory Affairs Lead
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C. W.
    Clinical Trials Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Senior Scientist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.